share_log

MusclePharm (OTCMKTS:MSLP) Stock Crosses Below 200 Day Moving Average of $0.21

MusclePharm (OTCMKTS:MSLP) Stock Crosses Below 200 Day Moving Average of $0.21

MusclePharm(场外交易代码:MSLP)股价跌破200日移动均线0.21美元
Defense World ·  2022/10/06 03:11

MusclePharm Co. (OTCMKTS:MSLP – Get Rating)'s stock price crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.21 and traded as low as $0.13. MusclePharm shares last traded at $0.16, with a volume of 5,541 shares trading hands.

在周三的交易中,MusclePharmCo.的股价跌破了200日移动均线,200日移动均线切入位0.21美元,最低交易价格为0.13美元,最后报0.16美元,总成交量为5541股。

MusclePharm Trading Up 11.7 %

MusclePharm股价上涨11.7%

The stock has a 50-day moving average of $0.18 and a two-hundred day moving average of $0.21. The firm has a market cap of $5.26 million, a price-to-earnings ratio of -0.27 and a beta of 0.38.

该股的50日移动均线切入位在0.18美元,200日移动均线切入位在0.21美元。该公司市值为526万美元,市盈率为-0.27倍,贝塔系数为0.38。

MusclePharm Company Profile

MusclePharm公司简介

(Get Rating)

(获取评级)

MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products.

公司在美国和国际上开发、制造、营销和分销运动营养品和营养补充剂。该公司提供一系列高性能粉末、胶囊、片剂、凝胶和随时可用的零食。该公司的MusclePharm品牌产品组合包括战斗蛋白粉和战斗挤压蛋白棒;以及支链氨基酸、肌酸、谷氨酰胺、肉碱、共轭亚油酸、鱼油、多种维生素和其他产品等基本补充剂。

Featured Stories

专题报道

  • Get a free copy of the StockNews.com research report on MusclePharm (MSLP)
  • 3 Alzheimer Stocks to Buy as the Race for a Cure Heats Up
  • Don't Forget About These Cheap, Fundamentally Strong Tech Stocks
  • Bellwether RPM International Pops On Results
  • Rivian Checks Off Boxes, But Still Needs a Lot to Go Right
  • Hot Potato: Lamb Weston Stock Confirms a Top
  • 免费获取StockNews.com关于MusclePharm的研究报告(MSLP)
  • 随着治疗竞赛升温,3只阿尔茨海默病股票将被买入
  • 不要忘记这些廉价的、从根本上强劲的科技股
  • 领头羊RPM国际流行业绩
  • Rivian打掉了包袱,但仍有很多事情要做
  • 辣土豆:韦斯顿羊肉库存涨幅居前

Receive News & Ratings for MusclePharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MusclePharm and related companies with MarketBeat.com's FREE daily email newsletter.

接受MusclePharm日报的新闻和评级-在下面输入您的电子邮件地址,即可通过MarketBeat.com的免费每日电子邮件时事通讯收到对MusclePharm和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发